- Home
- MSD vs THTX Comparison
MSD vs THTX Comparison
Compare MSD & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSD
- THTX
- Stock Information
- Founded
- MSD 1993
- THTX 1993
- Country
- MSD United States
- THTX Canada
- Employees
- MSD N/A
- THTX N/A
- Industry
- MSD Trusts Except Educational Religious and Charitable
- THTX Biotechnology: Pharmaceutical Preparations
- Sector
- MSD Finance
- THTX Health Care
- Exchange
- MSD Nasdaq
- THTX Nasdaq
- Market Cap
- MSD 152.3M
- THTX 144.8M
- IPO Year
- MSD N/A
- THTX N/A
- Fundamental
- Price
- MSD $7.43
- THTX $3.22
- Analyst Decision
- MSD
- THTX Hold
- Analyst Count
- MSD 0
- THTX 1
- Target Price
- MSD N/A
- THTX N/A
- AVG Volume (30 Days)
- MSD 70.2K
- THTX 246.5K
- Earning Date
- MSD 01-01-0001
- THTX 10-09-2025
- Dividend Yield
- MSD 11.26%
- THTX N/A
- EPS Growth
- MSD N/A
- THTX N/A
- EPS
- MSD N/A
- THTX N/A
- Revenue
- MSD N/A
- THTX $84,378,000.00
- Revenue This Year
- MSD N/A
- THTX N/A
- Revenue Next Year
- MSD N/A
- THTX $13.76
- P/E Ratio
- MSD N/A
- THTX N/A
- Revenue Growth
- MSD N/A
- THTX 2.19
- 52 Week Low
- MSD $6.11
- THTX $1.12
- 52 Week High
- MSD $7.46
- THTX $3.24
- Technical
- Relative Strength Index (RSI)
- MSD 38.16
- THTX 72.32
- Support Level
- MSD $7.39
- THTX $3.18
- Resistance Level
- MSD $7.49
- THTX $3.24
- Average True Range (ATR)
- MSD 0.05
- THTX 0.02
- MACD
- MSD 0.01
- THTX -0.01
- Stochastic Oscillator
- MSD 28.57
- THTX 77.78
About MSD Morgan Stanley Emerging Markets Debt Fund Inc.
Morgan Stanley Emerg Mkts Debt Fd Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to produce high current income and as a secondary objective to seek capital appreciation, through investments mainly in debt securities of government and government-related issuers located in emerging countries, of entities organized to restructure the outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries.
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.